Seraplex, Inc.

Based in the US, Seraplex, Inc. , operates as a provider of blood products for diagnostics. Based in Pasadena, the US and founded in 1974, Seraplex, Inc. specializes in the distribution of blood products essential to the diagnostic and biopharmaceutical sectors.

The company has a history of sourcing surplus blood products from hospitals and blood centers. In October 2026, Prairie Capital acquired Seraplex, Inc. Financial terms were not disclosed. Seraplex, Inc.

specializes in the distribution of blood products essential to the diagnostic and biopharmaceutical sectors. The company offers a range of products including Recovered Frozen Plasma, Cord Red Cells, Cord Whole Blood, and Cord Plasma, which are pivotal for in vitro diagnostic manufacturing and therapeutic applications. Their primary customer base consists of manufacturers that utilize these blood products in various medical and research applications, ensuring that vital biological materials are efficiently allocated to meet industry demands. Seraplex's products are distributed globally, providing critical solutions to diagnostic and therapeutic manufacturers in North America, Europe, and Asia.

Seraplex, Inc. engages directly with clients in the medical and biopharmaceutical fields through a B2B model. The company emphasizes partnerships and long-term agreements with hospital blood banks and plasma fractionation entities to facilitate the supply of their products. Revenue generation stems from selling blood products through contracts that align with the purchasing needs of their clients, with pricing structures varying based on product type and volume.

In October 2026, Prairie Capital acquired Seraplex, Inc. to expand its biospecimen platform with specialty blood products and disease-state samples.